Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA
/in Hepatocellular Carcinoma, International Publications /von 2006-02-10 / Cell. Immunol. 2005 Nov;238(1):61-6Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2006-01-01 / Cytotherapy 2006;8(6):580-8Immunological treatment of liver tumors
/in Hepatocellular Carcinoma, International Publications /von 2005-11-14 / World J. Gastroenterol. 2005 Nov;11(42):6571-6Administration of dendritic cells in cancer nodules in hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2005-10-01 / Oncol. Rep. 2005 Oct;14(4):969-73Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses
/in Hepatocellular Carcinoma, International Publications /von 2005-09-28 / World J. Gastroenterol. 2005 Sep;11(36):5614-20Immune-related effects of local hyperthermia in patients with primary liver cancer
/in Hepatocellular Carcinoma, International Publications /von 2005-09-01 / Hepatogastroenterology 2005 Sep-Oct;52(65):1502-6Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):496-504Activation of dendritic cells by local ablation of hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2005-06-20 / J. Hepatol. 2005 Nov;43(5):817-22[Clinical effects of dendritic cells pulsed with autologous hepatoma cell lysates on the postoperative recurrence and metastasis of hepatocellular carcinoma]
/in Hepatocellular Carcinoma, International Publications /von 2005-06-01 / Zhonghua Gan Zang Bing Za Zhi 2005 Jun;13(6):432-5
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
- Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
- Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy